Protokoly_diagnostiki_i_lechenia_zabolevany

/ , & :

1.Hopkins A., Appleton R. Epilepsy: Oxford University Press.1996.

2.6 % 10 ;

3.6 % & 3 (ILAE).Epilepsia 1989 vol. 30-P.389-399.

4..M.6 , ?.!. «B " 3 : , ," ».6.,2000 .

5.@ " 3 . .?.; , 6.M.+ , 1997 .

6.! 3 " 3- ( J - ). .M. 6 , ?.!. , +.<.. H" - . . 6H, 6 , 2002 .

7.Progress in Epileptic Disorders «Cognitive Dysfunction in Children with Temporal Lobe Epilepsy». France, 2005.

8.Aicardi J. Epilepsy in children.-Lippincott- Raven, 1996.- .44-66.

9.Marson AG, Williamson PR, Hutton JL, Clough HE, Chadwick DW, on behalf of the epilepsy monotherapy trialists. Carbamazepine versus valproate monotherapy for epilepsy. In: The Cochrane Library, Issue 3, 2000;

10.Tudur Smith C, Marson AG, Williamson PR. Phenotoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. In: The Cochrane Library, Issue 4, 2001;

11.@ & . >% " . L & 2. 6 , 6 ! , 2003. 833-836.

12.First Seizure Trial Grroup (FIRST Group). Randomized clinical trial on the efficacy of antiepilepic drugs in reducing the risk of relapse after a first unprovoked tonic clonic seizure. Neurology 1993;43: 478-483;

13.Medical Research Council Antiepileptic Drug Withdrawal Study Group. Randomised study of antiepilepic drug withdrawal in patients in remission. Lancet 1991; 337: 1175-1180.

14." $# " , &, 2- . 7 ;? -6>@, 2002, !. 933-935.

15.Never rugs for epilepsy in children. National Institute for Clinical Excellence. Technology Appraisal 79. April 2004. http://www.clinicalevidence.com.

16.Brodie MJ. Lamotrigine monoterapy: an overview. In: Loiseau P (ed). Lamictal – a brighter future. Royal Sosiety of Medicine Hress Ltd, London, 1996, pp 43-50.

17.O’Brien G et al. Lamotrigine in add-on terapy in treatment-resistant epilepsy in mentallyhandicapped patients: an interim analisis. Epilepsia 1996, in press.

18.Karseski S., Morrell M., Carpenter D. The Expert Consensus Guideline Series: Treatment of Epilepsy. Epilepsia Epilepsy Behav. 2001; 2:A1-A50.

19.Hosking G et al. Lamotrigine in children with severe developmental abnormalities in a pediatric population with refractory seizures. Epilepsia 1993; 34 (Suppl): 42

20.Mattson RH. Efficacy and adverse effects of establiched and new antiepileptic drugs. Epilepsia 1995; 36 (suppl 2): 513-526.

21.'.'., D >.'., " ;.?., ! J.'., @.?., )

22.Barry J., Lembke A., Huynh N. Affective disorders in epilepsy. In: Psychiatric issues in epilepsy. A practical guide to diagnosis and treatment. A. Ettinger, A. Kanner (Eds.). Philadelphia 2001; 45-71.

23.Blumer D., Montouris G., Hermann B. Psychiatric morbidity in seizure patients on a neurodiagnostic monitoring unit. J. Neuropsychiat Clin Neurosci 1995; 7:445-446.

24.Edeh J., Toone B., Corney R. Epilepsy, psychiatric morbidity, and social dysfunction in general

practice. Comparison between hospital clinic patients and clinic non-attenders. Neuropsychiat Neuropsychol Behav Neurol 1990; 3: 180-192.

25.Robertson M., Trimble M., Depressive illness in patients with epilepsy: a review. Epilepsia 1983; 24: Supple 2:109-116.

26.Schmitz B., Depressive disorders in epilepsy. In: Seizure, affective disorders and anticonvusant drugs. M. Trimble, B. Schmitz (Eds.). UK 2002; 19-34.

* – , # (% % )

; $

: 01-015

"$ &: " :

& ! :

' & & : 13

(: G91.0 ! #$# Q 0.03 ' % ,

P 37.1 ' % G91.1

G91.2 &

G91.3 " " G 91.8 @

G 91.9 "

) : ; $ ( ) – , $# " & % % " " ", %$# ,. "# " " .

$ :

:

1.% ;

2..

" "$:

1.$# ;

2..$ ( ) :

1.$ 6 ;

2.& ;

3.6 % J$. ! #$# ( ):

1.;

2..

% " & :

1.;

2.% .

* :

1. % ;

2.& ( & );

3.;

4.& ;

5.;

6." - ;

7.;

8.;

9..

" :

" 1,5 # 1 . _"$ / / (0,7 / ). @/ / 15% 255 & (0,2 / ). J " " " ( , #$# )& % .

3. , "$# # – 3 100 . 4.@ - , $ & , 1-2 / 2-33 +, 2 - , . ' # 1 % " 70-80 / , 2- % %$ 50 / .

" & :

1.*? + 625 ; V 600 ;

2.*6 10%, 20% 100 , 500 ;

3.*_ 40 .; 20 /2 .;

4.*? 250 .

" & & :

1.G 50 .;

2.! & 50 .;

3.*6 & 25% 20 .

,- ! :

1. !- .

4.The Maternal and Child Health Forum. Childhood Disease. Hydrocephaly.2005. www.clinicalevidence.com

5.M.'. &. «L ». +BB . 2004 . kuszel@nsi.ru

6.Management of Spina Bifida, Hydrocephalus and Shunts Last Updated. 2004. www.g-i-n.net

7.A Resource Guide for Children and Adults With Developmental Disabilities Living in King County. About Hydrocephalus. 2002. http://www.patientcenters.com/hydrocephalus

8.? & B.?., @ " 6.J., ? ?.?. .«B & ». 1999.

http://www.rbc.ru

9.« $# ». G " '.?.. . ? , !.-., 1999 .;

10.Burton B.K. Reccurence risks for congenital hydrocephalicus . 1979.;

11.!.B. . «+ -" & ». 6., 1996 .

* – , # (% % )

3.B , " ;

4.7 ;

5.B – , % " &

6." " ( " -);

7.! " ;

8..

+ :

1. # : & % $# ,& (1 – 2 "), , $# "

(" 5–6 ) " & 0,3 , – 0,4 ( & ) .

6. ? : * 12,5- 25 ; 7. ? : * 3-6 0,01 -0,02 , 7-12 0,02-0,03 ; 13

- 0,03-0,04 ; * – 0,05 – 0,5 1 2 & 8. ! : * 2,5–5 ( 2 ).

9." : * 12,5–25 1–3 &;

10.? : * – 0,25 – 1 2 &; * – 0,05 – 0,1 3 &.

" % & (- ) J_.

14. & & .& (& % " ").

" & :

1.*@ 0,1 , 0,2 , .; 0,2 /1 .;

2.*? 250 , .;

3. *? 0,1%, 0,5%, 1% 1 ( );

4.6 5 , .;

5.* 200 , .; 20% 5 , .;

6.*@ 5 , 10 , .; 10 /2 , .

" & & :

1.? 0,01 -0,02 , ;

2.? 25 , .; 2 /20 .;

3.* 500 /1000 .

/ , & :

1.@ " " . " >, 2001. http://pdateam.ru/

2.F.A.M. van Balen; P.J.A.M. Baselier; >. van Pienbroek; R.A.G. Winkens. B " . ! # " . 2004. http://www.drsex.ru

3.B6! +>' +>;. @ &-" ," . 2000. http://www.osdm.org/

4.?.&. @ A , @.&. " , =./. # . " .

* – , # (% % )

' % ! ( &)

: 10-106"

"$ &: "

:

& ! :

1. " ;

2.3 !; ;

3." .

' & & : 21 &(:

E34 @ 3

E34.3 + & ( &), ) : & – " & ( 2 SDS – & , – 145 . % # , 155 . %" ).

+ & – 3 " . + " & " /% %(!; ). + "$ &- (/ +)!; .

– :

1)" & !; ;

2)" & !; " " &$;

3)% ;

2.! % !;- $# .

3.@ – J .

4.+ " & B_ 1.

4.1. " $ B_ 1 & B_ 2.

4.2.& .

4.3.B_ 1.

4.4.B_ 1. <.1. ' % .

1.1.@ :

) 3 , ;

) "& "& &.

II. " &:

1.: , , , , ( , );

2.: " % , ", , " - , " & " ;

3.: , , ;

4.& : , , ,, ;

5.- , ,;

6.& , “ ” .– 3 :

1.( );

2.( );

3.( );

2.;

3.& ;

4.( K-; );

5.& " ;

6.&;

7..

* :

1." ( , );

2.3 ( % , " &

B_ 1 );